|
Healthcare Solutions
International (Pvt) Limited (“HSI”) is presently offering
Retrodifferentiated Stem Cell Therapy invented by Dr. Ilham Saleh
Abuljadayel to treat several previously untreatable indications
such as Aplastic Anaemia, Thalassaemia, Sickle Cell Anaemia,
Spinal Cord Injury, Degenerative Neurological Disorders such as
Parkinsons, Alzheimers, Motor Neuron Disease, Multiple Sclerosis,
Muscular Dystrophy, Cerebellar Ataxia, Organ (Liver and Kidney)
Dysfunction, Hepatitis C, Diabetes Type I and II and Congestive
Heart Failure (CHF).
TriStem’s unique
patented Retrodifferentiation technology is based on the results
of 15 years of research. The main advantage of TriStem's
pioneering and patented process over existing methods of
harvesting stem cells is that it obviates the need to use human
donor cells, embryos or foetuses and, therefore, bypasses the
controversial process of therapeutic cloning, is cost effective
and provides large quantities of stem cells which are by
definition DNA matched.
|
